AnsinelliRadOnc's profile picture. Father, Husband, Radiation Oncologist at @AZOncology, Tucson AZ. Views my own.

Hayden Ansinelli

@AnsinelliRadOnc

Father, Husband, Radiation Oncologist at @AZOncology, Tucson AZ. Views my own.

Hayden Ansinelli reposted

A key to not have burnout is to be at a great program where people are appreciated, heard, and can be change agents.


Hayden Ansinelli reposted

#ASTRO25 Getting ready for ARRO/ASTRO/ABS resident workshop. For HDR prostate start w anterior needles and work posterior to avoid shadowing that can impact placement. Also, ABS prostate school coming up with more tips! americanbrachytherapy.org/meetings-event… @AmericanBrachy @ARRO_org

KamravaMD's tweet image. #ASTRO25 Getting ready for ARRO/ASTRO/ABS resident workshop.  For HDR prostate start w anterior needles and work posterior to avoid shadowing that can impact placement. 
Also, ABS prostate school coming up with more tips! 
americanbrachytherapy.org/meetings-event…
@AmericanBrachy @ARRO_org

Hayden Ansinelli reposted

Congratulations to my dear colleague @ArjitB_medphys on receiving the @MethodistHosp I CARE award. Not only is he a #medphys #brachytherapy guru. He’s an all around great human being and patient advocate. Great to see him recognized! #bteam

AndrewFarach's tweet image. Congratulations to my dear colleague @ArjitB_medphys on receiving the @MethodistHosp I CARE award. Not only is he a #medphys #brachytherapy guru. He’s an all around great human being and patient advocate. Great to see him recognized! 

#bteam

Hayden Ansinelli reposted

Huge surprise at resident graduation ceremony this past week to have received this! Humbled and honored. For me, the highlight of academic medicine is the opportunity/privilege to teach! ⁦Glad to see the residents don’t mind working with me 🙃 ⁦@OhioStateRadOnc⁩ ⁦

Raj_Singh_MD's tweet image. Huge surprise at resident graduation ceremony this past week to have received this! Humbled and honored.  For me, the highlight of academic medicine is the opportunity/privilege to teach! ⁦Glad to see the residents don’t mind working with me 🙃 ⁦@OhioStateRadOnc⁩ ⁦

Hayden Ansinelli reposted

First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser

Sushilberiwal's tweet image. First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser
Sushilberiwal's tweet image. First hybrid brachytherapy in Guatemala @AmericanBrachy @KamravaMD @AndrewKellerMD @DocGlaser

Hayden Ansinelli reposted

Hey @BCBSM can you explain to me why you won’t approve prostate SBRT in a patient with intermediate risk prostate cancer? And then I come to find out you want a 3D comparison if I want to use IMRT? You clearly don’t care about the wellbeing of the patient. Despicable…


Hayden Ansinelli reposted

🚨 We’re hiring not one but TWO medical oncologists in Parkersburg, WV, a welcoming community with real need, a big heart, and a team that’s ready to support you. A chance to truly make a difference in a community of need: wvumedicine.wd1.myworkdayjobs.com/UHA/job/Camden…

jryckman3's tweet image. 🚨 We’re hiring not one but TWO medical oncologists in Parkersburg, WV, a welcoming community with real need, a big heart, and a team that’s ready to support you. A chance to truly make a difference in a community of need:
wvumedicine.wd1.myworkdayjobs.com/UHA/job/Camden…

Hayden Ansinelli reposted

🚀 Ready to elevate your expertise? Register now for #ABSBrachy25 & join key thought leaders in Nashville! Don't miss the chance to connect, learn, and innovate in the field of #brachytherapy.🏙️ #Brachytherapy bit.ly/4iCD1ae @andrewfarach @marisakollmeier @KamravaMD


Hayden Ansinelli reposted

Just ask Bob 🎨, #brachytherapy is the ultimate in dose painting A great tx option for nodular #prostatecancer fossa recurrences in upfront & reRT settings. Allows for OAR sparing and dose escalation. #300in10 fellow collab sciencedirect.com/science/articl… #pcsm #radonc

HDR brachytherapy salvage for nodular prostate fossa recurrence: A mechanistic review and initial report of clinical outcomes brachyjournal.com/article/S1538-… this comes up but limited data nice small series @AndrewFarach Also, UCSF PMID: 36623988 and Europe series PMID: 37425206



Hayden Ansinelli reposted

Great to catch up with fellow ⁦@MUSOMWV⁩ ‘18 grad and #RadOnc@AnsinelliRadOnc⁩ while in AZ! Go Herd!

Raj_Singh_MD's tweet image. Great to catch up with fellow ⁦@MUSOMWV⁩ ‘18 grad and #RadOnc ⁦@AnsinelliRadOnc⁩ while in AZ! Go Herd!

Hayden Ansinelli reposted

For anyone interested in the #300in10 mini-fellowship to develop expertise in #brachytherapy this is a must listen! 👂 Thanks to @MAgarwalMD1 and @KrcRebecca for highlighting the work of the @HMethodistMD #Bteam! Now 12 training sites in the 🇺🇸&🇨🇦 americanbrachytherapy.org/resources/fell…

Don't miss out on #BrachyBites Episode 12! Join @MAgarwalMD1 and @KrcRebecca as they dive into the transformative #ABS300in10 2-month fellowship program focusing on advancing #brachy. bit.ly/4a0Lf8Z #ThisIsBrachytherapy #brachytherapy

AmericanBrachy's tweet image. Don't miss out on #BrachyBites Episode 12! Join @MAgarwalMD1 and @KrcRebecca  as they dive into the transformative #ABS300in10 2-month fellowship program focusing on advancing #brachy. bit.ly/4a0Lf8Z #ThisIsBrachytherapy #brachytherapy


Hayden Ansinelli reposted

Dear @Humana, my patient with oligometastatic prostate cancer (CHAARTED-defined) qualifies for prostate-directed radiotherapy per STAMPEDE Arm H—a Phase III trial showing overall survival benefit. Despite 3D radiotherapy approval, IMRT was denied. I was denied peer-to-peer review…


Hayden Ansinelli reposted

Mark your calendar: The 2025 Radiosurgery Society Scientific Meeting will be held March 20-22, 2025 in Tucson, AZ. Look out for registration info in July! #2025RSS

the_RSS's tweet image. Mark your calendar: The 2025 Radiosurgery Society Scientific Meeting will be held March 20-22, 2025 in Tucson, AZ. Look out for registration info in July! #2025RSS

Hayden Ansinelli reposted

@evicorehc @AnthemBCBS denying IMRT over 3D for a young breast cancer in a patient < 40 - 3D plan not meeting constraints, plan sent. Denied. Staff told there is NO option for a “peer”-to-peer or reconsideration. !? This should be a no brainer. Do better for my patient @evicorehc


Hayden Ansinelli reposted

Sad to see that IMRT is not covered by @UHC @askUHC for limited stage small cell lung cancer, particularly given encouraging findings regarding dose escalation vs. SoC from two Phase II trials, known association of heart dose on survival, and @NCCN recommending IMRT over 3D-CRT.


Hayden Ansinelli reposted

it’s always gratifying to see your trainee Phil pifer now extending state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys

Sushilberiwal's tweet image. it’s always gratifying to see your trainee Phil pifer now extending  state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys
Sushilberiwal's tweet image. it’s always gratifying to see your trainee Phil pifer now extending  state of the art kelowna hybrid brachytherapy in the state of West Virginia @bindhu2102 @AndrewKellerMD @AmericanBrachy @KamravaMD @VarianMedSys

Hayden Ansinelli reposted

Spent the week with my mom. Radiation and multiple surgeries for a high grade liposarcoma left her unable to sit for the better part of 8 months. Now here she is, sitting and cancer free.

DGlaucomflecken's tweet image. Spent the week with my mom. Radiation and multiple surgeries for a high grade liposarcoma left her unable to sit for the better part of 8 months. Now here she is, sitting and cancer free.

Hayden Ansinelli reposted

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ @IASLC @MDAndersonNews @TheLancet @ACKoongMDPhD @StephenVLiu

JoeChangMD's tweet image. Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC 
@MDAndersonNews @TheLancet @ACKoongMDPhD 
@StephenVLiu
JoeChangMD's tweet image. Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC 
@MDAndersonNews @TheLancet @ACKoongMDPhD 
@StephenVLiu

Hayden Ansinelli reposted

The great ⁦@Raj_Singh_MD⁩ sharing his study utilizing #SBRT in extracranial sarcoma metastases at #RSS2023@the_RSS@OSUWexMed⁩ ⁦@VCUMassey⁩ ⁦@VCURadOncRes

EricLehrer's tweet image. The great ⁦@Raj_Singh_MD⁩ sharing his study utilizing #SBRT in extracranial sarcoma metastases at #RSS2023 ⁦@the_RSS⁩ @OSUWexMed⁩ ⁦@VCUMassey⁩ ⁦@VCURadOncRes⁩

Loading...

Something went wrong.


Something went wrong.